Distinct Clinical Outcomes of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor (EGFR) Mutations Treated with EGFR Tyrosine Kinase Inhibitors: Non-Responders versus Responders-Reference-Cited by-同舟云学术

Distinct Clinical Outcomes of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor (EGFR) Mutations Treated with EGFR Tyrosine Kinase Inhibitors: Non-Responders versus Responders

Published:2013-12-23 Issue:12 Volume:8 Page:e83266
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hsiao Shih-Hsin,Liu H. Eugene,Lee Hsin-Lun,Lin Chii-Lan,Chen Wei-Yu,Wu Zhung-Han,Lin Sey-En,Chiang Ling-Ling,Chung Chi-Li

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference14 articles.

1. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;TJ Lynch;N Engl J Med,2004

2. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;TS Mok;N Engl J Med,2009

3. American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy;VL Keedy;J Clin Oncol,2011

4. Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: a combined clinical-molecular pathological approach;M Salto-Tellez;J Thorac Oncol,2011

5. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial;T Mitsudomi;Lancet Oncol,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of tumor abnormal protein expression and epidermal growth factor receptor mutation status in non-small cell lung cancer;Discover Oncology;2024-07-09

2. Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Targeted Therapy in Lung Adenocarcinoma Cell Lines;Cancers;2024-07-08

3. Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes;Cancer Epidemiology;2022-02

4. A Prospective Observational Study Evaluating the Correlation of c-MET Expression and EGFR Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung Cancer;Oncology;2018

5. Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors;OncoTargets and Therapy;2017-04